Original product for Losartan can be reproduced and prescribed in early February. Organon's HTN treatment Cozaar XQ, which was suspended due to detection of impurities above the standard last year, will be resupplied at the end of this month.

Organon (CEO Kim So-eun) announced on the 27th that it will be able to re-supply Cozaar XQ from the end of this month and prescribe it from early February. Cozaar XQ, the original product, was suspended from shipping after an impurity test conducted in November last year detected more than the standard level. No impurities were detected in the same Losartan, Cozaar and Cozaar Plus. Organon replaced Cozaar XQ with French raw materials such as Cozaar and Cozaar Plus